lrcx-20220727
false000070754900007075492022-07-272022-07-27
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 27, 2022
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 0-12933 94-2634797
(State or Other Jurisdiction
of Incorporation)
 (Commission
File Number)
 (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareLRCXThe Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                     


Table of Contents
Table of Contents
 
Item 2.02.  Results of Operations and Financial Condition
Item 9.01.  Financial Statements and Exhibits
SIGNATURES
EX-99.1



Table of Contents
 Item 2.02.Results of Operations and Financial Condition
On July 27, 2022, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended June 26, 2022, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01.Financial Statements and Exhibits
(d) Exhibits
99.1
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document



Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:July 27, 2022
LAM RESEARCH CORPORATION
(Registrant)
 /s/ Douglas R. Bettinger
 Douglas R. Bettinger
 Executive Vice President, Chief Financial Officer
 (Principal Financial Officer and Principal Accounting Officer)
 


Document

Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended June 26, 2022
FREMONT, Calif., July 27, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended June 26, 2022 (the “June 2022 quarter”).
Highlights for the June 2022 quarter were as follows:
Revenue of $4.64 billion.
U.S. GAAP gross margin of 45.3%, U.S. GAAP operating income as a percentage of revenue of 31.9%, and U.S. GAAP diluted EPS of $8.74.
Non-GAAP gross margin of 45.2%, non-GAAP operating income as a percentage of revenue of 31.5%, and non-GAAP diluted EPS of $8.83.
Key Financial Data for the Quarters Ended
June 26, 2022 and March 27, 2022
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
 June 2022March 2022Change Q/Q
Revenue$4,635,554 $4,060,416 +14%
Gross margin as percentage of revenue45.3 %44.7 %+ 60 bps
Operating income as percentage of revenue31.9 %29.4 %+ 250 bps
Diluted EPS$8.74 $7.30 +20%
Non-GAAP
 June 2022March 2022Change Q/Q
Revenue$4,635,554 $4,060,416 +14%
Gross margin as percentage of revenue45.2 % 44.7 %+ 50 bps
Operating income as percentage of revenue31.5 % 29.4 %+ 210 bps
Diluted EPS$8.83  $7.40 +19%

U.S. GAAP Financial Results
For the June 2022 quarter, revenue was $4,636 million, gross margin was $2,101 million, or 45.3% of revenue, operating expenses were $621 million, operating income was 31.9% of revenue, and net income was $1,209 million, or $8.74 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,060 million, gross margin of $1,817 million, or 44.7% of revenue, operating expenses of $625 million, operating income of 29.4% of revenue, and net income of $1,022 million, or $7.30 per diluted share, for the quarter ended March 27, 2022 (the “March 2022 quarter”).
Non-GAAP Financial Results
For the June 2022 quarter, non-GAAP gross margin was $2,094 million, or 45.2% of revenue, non-GAAP operating expenses were $635 million, non-GAAP operating income was 31.5% of revenue, and non-GAAP net income was $1,221 million, or $8.83 per diluted share. This compares to non-GAAP gross margin of $1,815 million, or 44.7% of revenue, non-GAAP operating expenses of $621 million, non-GAAP operating income of 29.4% of revenue, and non-GAAP net income of $1,036 million, or $7.40 per diluted share, for the March 2022 quarter.
“Lam delivered record levels of revenue and earnings per share in the June quarter, while continuing to operate in a supply-constrained environment,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “With solid operational execution, technology leadership, and a robust installed base business, Lam is well-positioned for long-term growth.”






Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $3.9 billion at the end of the June 2022 quarter compared to $4.6 billion the end of the March 2022 quarter. This decrease was primarily the result of $876.1 million of share repurchases, including net share settlement of employee stock-based compensation; $208.1 million of dividends paid to stockholders; and $125.7 million of capital expenditures, partially offset by $443.9 million of cash generated by operating activities.
Deferred revenue at the end of the June 2022 quarter increased to $2,198 million compared to $2,069 million as of the end of the March 2022 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptances. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $367 million as of June 26, 2022 and $263 million as of March 27, 2022.
Revenue
The geographic distribution of revenue during the June 2022 quarter is shown in the following table:
RegionRevenue
China31%
Korea24%
Taiwan19%
United States8%
Europe7%
Japan6%
Southeast Asia5%
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months EndedTwelve Months Ended
June 26,
2022
March 27, 2022June 27,
2021
June 26,
2022
June 27,
2021
(In thousands)
Systems revenue$3,006,374 $2,650,842 $2,763,877 $11,322,271 $9,764,845 
Customer support-related revenue and other1,629,180 1,409,574 1,381,302 5,904,768 4,861,305 
$4,635,554 $4,060,416 $4,145,179 $17,227,039 $14,626,150 
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook
For the quarter ended September 25, 2022, Lam is providing the following guidance:
U.S. GAAPReconciling ItemsNon-GAAP
Revenue$4.9 Billion+/-$300 Million$4.9 Billion+/-$300 Million
Gross margin as a percentage of revenue45.0%+/-1%$Million45.0%+/-1%
Operating income as a percentage of revenue31.4%+/-1%$Million31.5%+/-1%
Net income per diluted share$9.48+/-$0.75$Million$9.50+/-$0.75
Diluted share count137 Million137 Million
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or realized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:
Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.



Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $3 million.
Net income per diluted share - amortization related to intangible assets acquired though business combinations, $3 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($1 million); totaling $3 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the June 2022 and March 2022 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax benefit of non-GAAP items.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at https://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; our operational execution and technology leadership; the strength of our installed base business; and our prospects for growth. Some factors that may affect these forward-looking statements include: supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021, and our quarterly reports on Form 10–Q for the fiscal quarters ended September 26, 2021, December 26, 2021 and March 27, 2022. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
 ###





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
 Three Months EndedTwelve Months Ended
 June 26,
2022
March 27,
2022
June 27,
2021
June 26,
2022
June 27,
2021
(unaudited)(unaudited)(unaudited)(unaudited)(1)
Revenue$4,635,554 $4,060,416 $4,145,179 $17,227,039 $14,626,150 
Cost of goods sold2,535,042 2,243,791 2,229,978 9,355,232 7,820,844 
Gross margin2,100,512 1,816,625 1,915,201 7,871,807 6,805,306 
Gross margin as a percent of revenue45.3 %44.7 %46.2 %45.7 %46.5 %
Research and development411,157 407,120 381,749 1,604,248 1,493,408 
Selling, general and administrative210,002 217,408 217,525 885,737 829,875 
Total operating expenses621,159 624,528 599,274 2,489,985 2,323,283 
Operating income1,479,353 1,192,097 1,315,927 5,381,822 4,482,023 
Operating income as a percent of revenue31.9 %29.4 %31.7 %31.2 %30.6 %
Other expense, net(120,448)(57,402)(7,166)(188,708)(111,219)
Income before income taxes1,358,905 1,134,695 1,308,761 5,193,114 4,370,804 
Income tax expense(149,971)(112,917)(164,104)(587,828)(462,346)
Net income$1,208,934 $1,021,778 $1,144,657 $4,605,286 $3,908,458 
Net income per share:
Basic$8.76 $7.34 $8.02 $32.92 $27.22 
Diluted$8.74 $7.30 $7.98 $32.75 $26.90 
Number of shares used in per share calculations:
Basic137,993 139,229 142,662 139,899 143,609 
Diluted138,313 140,057 143,514 140,628 145,320 
Cash dividend declared per common share$1.50 $1.50 $1.30 $6.00 $5.20 
(1)Derived from audited financial statements.














 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
June 26,
2022
March 27,
2022
June 27,
2021
(unaudited)(unaudited)(1)
ASSETS
Cash and cash equivalents$3,522,001 $4,194,719 $4,418,263 
Investments135,731 160,072 1,310,872 
Accounts receivable, net4,313,818 3,702,320 3,026,430 
Inventories3,966,294 3,479,332 2,689,294 
Prepaid expenses and other current assets347,391 351,658 207,528 
Total current assets12,285,235 11,888,101 11,652,387 
Property and equipment, net1,647,587 1,561,875 1,303,479 
Restricted cash and investments251,534 251,036 252,487 
Goodwill and intangible assets1,616,963 1,627,035 1,622,499 
Other assets1,394,313 1,260,984 1,061,300 
Total assets$17,195,632 $16,589,031 $15,892,152 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations$7,381 $7,689 $11,349 
Other current liabilities4,557,378 4,187,052 3,516,518 
Total current liabilities4,564,759 4,194,741 3,527,867 
Long-term debt and finance lease obligations4,998,449 5,000,657 4,990,333 
Income taxes payable931,117 916,668 948,037 
Other long-term liabilities422,941 450,475 398,727 
Total liabilities10,917,266 10,562,541 9,864,964 
Stockholders’ equity (2)6,278,366 6,026,490 6,027,188 
Total liabilities and stockholders’ equity$17,195,632 $16,589,031 $15,892,152 
 
(1)Derived from audited financial statements.
(2)
Common shares issued and outstanding were 136,975 as of June 26, 2022, 138,707 as of March 27, 2022, and 142,501 as of June 27, 2021
 





 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 Three Months EndedTwelve Months Ended
 June 26,
2022
March 27,
2022
June 27,
2021
June 26,
2022
June 27,
2021
(unaudited)(unaudited)(unaudited)(unaudited)(1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$1,208,934 $1,021,778 $1,144,657 $4,605,286 $3,908,458 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization87,932 84,228 78,397 333,739 307,151 
Deferred income taxes(173,987)(56,878)(146,029)(257,438)(151,477)
Equity-based compensation expense69,588 68,543 56,321 259,064 220,164 
Other, net33,574 (3,121)(27,786)(44,751)(17,392)
Changes in operating assets and liabilities(782,107)(356,840)330,375 (1,796,226)(678,741)
Net cash provided by operating activities443,934 757,710 1,435,935 3,099,674 3,588,163 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets(125,746)(145,368)(104,622)(546,034)(349,096)
Net sale of available-for-sale securities23,486 79,184 799,965 1,165,884 464,522 
Other, net26,323 (28,380)(6,282)(7,575)(42,155)
Net cash (used for) provided by investing activities(75,937)(94,564)689,061 612,275 73,271 
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt(2,032)(1,821)(822,046)(11,889)(862,060)
Treasury stock purchases(876,089)(1,338,006)(431,255)(3,865,663)(2,697,704)
Dividends paid(208,056)(210,587)(185,385)(815,290)(726,992)
Reissuance of treasury stock related to employee stock purchase plan61,798 — 56,330 108,178 97,764 
Proceeds from issuance of common stock997 492 851 5,682 24,123 
Other, net(152)214 (269)45 (2,113)
Net cash used for financing activities(1,023,534)(1,549,708)(1,381,774)(4,578,937)(4,166,982)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(16,683)(5,090)702 (30,227)7,215 
Net (decrease) increase in cash, cash equivalents, and restricted cash(672,220)(891,652)743,924 (897,215)(498,333)
Cash, cash equivalents, and restricted cash at beginning of period4,445,755 5,337,407 3,926,826 4,670,750 5,169,083 
Cash, cash equivalents, and restricted cash at end of period$3,773,535 $4,445,755 $4,670,750 $3,773,535 $4,670,750 
(1)Derived from audited financial statements.




 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
June 26,
2022
March 27,
2022
Revenue$4,635,554 $4,060,416 
Gross margin$2,094,006 $1,814,910 
Gross margin as percentage of revenue45.2 %44.7 %
Operating expenses$634,631 $620,636 
Operating income$1,459,375 $1,194,274 
Operating income as a percentage of revenue31.5 %29.4 %
Net income$1,221,257 $1,036,359 
Net income per diluted share$8.83 $7.40 
Shares used in per share calculation - diluted138,313 140,057 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
June 26,
2022
March 27,
2022
U.S. GAAP net income$1,208,934 $1,021,778 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold1,308 1,153 
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold(7,814)(2,868)
EDC related liability valuation increase - research and development(14,065)(5,161)
Amortization related to intangible assets acquired through certain business combinations -selling, general and administrative9,969 12,494 
EDC related liability valuation increase - selling, general and administrative(9,376)(3,441)
Amortization of note discounts - other expense, net701 695 
Loss on EDC related asset - other expense, net32,316 13,118 
Net income tax benefit on non-GAAP items(716)(1,409)
Non-GAAP net income$1,221,257 $1,036,359 
Non-GAAP net income per diluted share$8.83 $7.40 
U.S. GAAP net income per diluted share$8.74 $7.30 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation138,313 140,057 




 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
June 26,
2022
March 27,
2022
U.S. GAAP gross margin$2,100,512 $1,816,625 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations1,308 1,153 
EDC related liability valuation increase(7,814)(2,868)
Non-GAAP gross margin$2,094,006 $1,814,910 
U.S. GAAP gross margin as a percentage of revenue45.3 %44.7 %
Non-GAAP gross margin as a percentage of revenue45.2 %44.7 %
U.S. GAAP operating expenses$621,159 $624,528 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations(9,969)(12,494)
EDC related liability valuation increase23,441 8,602 
Non-GAAP operating expenses$634,631 $620,636 
U.S. GAAP operating income$1,479,353 $1,192,097 
Non-GAAP operating income$1,459,375 $1,194,274 
U.S. GAAP operating income as percent of revenue31.9 %29.4 %
Non-GAAP operating income as a percent of revenue31.5 %29.4 %
 
Lam Research Corporation Contact:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com